Clinical Trial Update: Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration

View source ↗

Summary

A clinical trial is evaluating faricimab injections for neovascular age-related macular degeneration, and the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Hui Peng | Conditions: Neovascular Age-related Macular Degeneration(nAMD) | Status: NOT_YET_RECRUITING